Who bought & sold INM (Q2 2026)
Funds holding (Q2 2026)20
New positions14
Added0
Reduced3
Exited2
As of Q2 2026, 20 institutional funds reported holding INM (InMed Pharma Inc.): 14 opened new positions, 0 added, 3 trimmed and 2 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.
New positions (14)
| Fund | Shares | Value | Weight |
|---|---|---|---|
| ADAR1 Capital Management, LLC New | 800.00K | $1.24M | 0.1 |
| Vivo Capital, LLC New | 798.38K | $1.24M | 0.1 |
| Banque Cantonale Vaudoise New | 6 | $1.00M | — |
| Squadron Capital Management LLC New | 325.00K | $503.75K | 0.2 |
| Ikarian Capital, LLC New | 245.03K | $379.79K | 0.1 |
| Ursa Fund Management, LLC New | 125.80K | $194.99K | 0.0 |
| MONTANOVA CAPITAL, LLC New | 100.00K | $155.00K | 0.0 |
| BOOTHBAY FUND MANAGEMENT, LLC New | 74.24K | $115.08K | 0.0 |
| JANE STREET GROUP, LLC New | 43.08K | $66.77K | — |
| Venrock Adviser, LLC New | 32.69K | $50.66K | 0.0 |
| SEVEN GRAND MANAGERS, LLC New | 25.00K | $38.75K | 0.0 |
| Scientech Research LLC New | 15.46K | $23.96K | 0.0 |
| Crestwood Advisors Group, LLC New | 14.90K | $23.09K | — |
| Stratos Wealth Partners, LTD. New | 10.76K | $16.68K | — |
Added to positions (0)
No adds this quarter.
Reduced positions (3)
| Fund | Shares | Value | Weight | Change |
|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 44.97K | $69.70K | 0.5 | -175.29K sh (-79.6%) |
| Citadel Advisors | 26.08K | $40.43K | — | -20.89K sh (-44.5%) |
| TWO SIGMA SECURITIES, LLC | 10.95K | $16.96K | 0.0 | -7.77K sh (-41.5%) |
Exited positions (2)
Held in the prior quarter but not reported in the latest filing.
| Fund | Shares | Value | Weight |
|---|---|---|---|
| Virtu Financial LLC Exited | 19.98K | $13.00K | 0.0 |
| UBS Group AG Exited | 8.07K | $5.20K | — |